Pharmacology/ Therapeutics News for April 2019

Pharmacology/ Therapeutics News Archive

Maths made easier for scientists students who shun the subject wins award Maths made easier for scientists students who shun the subject wins award

Pharmacologist Dr Fraser Scott wins Royal Society of Chemistry award for his innovative approach to helping science students succeed in a maths-heavy module

Invokana® (canagliflozin) Significantly Reduces the Risk of Renal Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in the Landmark Phase 3 CREDENCE Study Invokana® (canagliflozin) Significantly Reduces the Risk of Renal Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in the Landmark Phase 3 CREDENCE Study

Invokana® (canagliflozin) is the only medicine in nearly 20 years and the first diabetes medicine to demonstrate significant reduction in risk of renal failure, dialysis or kidney transplantation and renal or cardiovascular (CV) death in this high-risk population